Projects (582)
Cardiff University Schools involved in this Project
ZIP transporter antibodies to inhibit zinc-mediated mitosis (01/02/2023 - 30/06/2024)
- Taylor, Kathryn
Zinc Transporter antibody cancer research (01/06/2022 - 30/06/2025)
- Taylor, Kathryn
Zinc transporter antibody - A potential cancer treatment (03/03/2020 - 31/03/2023)
- Taylor, Kathryn
Welsh NRN Life Sciences Health Related Biosciences Workshop (01/08/2017 - 31/01/2018)
- Brancale, Andrea
Welsh NRN life science drug delivery technology workshop (16/02/2015 - 30/09/2015)
- Mcguigan, Christopher
Welsh movement disorder e-Network for patients receiving Rasagiline (01/04/2013 - 31/03/2014)
Welsh Coronavirus Research (W-CoRe): A platform for the discovery of anti-betacoronaviruses agents (15/10/2020 - 31/03/2021)
- Brancale, Andrea
Welsh anti-microbial testing platform (01/06/2015 - 31/12/2018)
- Brancale, Andrea
Visualisation of biocide effect against Salmonella spp (08/11/2010 - 07/12/2010)
- Maillard, Jean-Yves
Visiting Student (01/04/2016 - 31/07/2017)
- Simons, Claire
Virucidal and tuberculodial infections (04/04/2016 - 03/04/2019)
- Maillard, Jean-Yves
Vector-borne emerging diseases: Computer-aided design, synthesis and evaluation of novel antiviral compounds against Chikungunya and Zika viruses (01/12/2016 - 30/11/2019)
- Bassetto, Marcella
Validating and explaining the presenting skills assessment for medics (01/07/2014 - 15/12/2018)
- Smith, Mathew
UV380 Microbial testing (03/10/2016 - 15/12/2016)
- Maillard, Jean-Yves
Utilising permipatch technology for the controlled and targeted delivery of potassium permanganate micro particles to wounds (01/08/2017 - 31/12/2017)
Using biodiversity research as catalyst for community based co-production studies (28/09/2020 - 31/05/2022)
- Baillie, Les
Using 'big data' to assess the quality of prescribing and medicines management for elderly care home residents (03/01/2017 - 02/01/2020)
- Smith, Mathew
Use of the ex-vivo test to evaluate the efficacy of antimicrobial topical formulations (05/12/2011 - 26/12/2011)
- Maillard, Jean-Yves
Use of minimally invasive technology platforms for extraction and delivery of dendritic cell vaccines (01/08/2017 - 31/10/2017)
- Birchall, James
Unlicensed “special” medicines: improving the patients’ experience (01/04/2018 - 15/04/2023)
- Mantzourani, Efi
Understanding the risk of emerging bacterial resistance to topical antibiotics (01/01/2020 - 31/12/2023)
- Maillard, Jean-Yves
Understanding the risk of emerging bacterial resistance to topical antibiotics (01/04/2019 - 31/08/2019)
- Maillard, Jean-Yves
Understanding the resilience of dry environmental microbial biofilms to disinfection (01/10/2018 - 01/04/2022)
- Maillard, Jean-Yves
Understanding the interactions of oxidising agents with macromolecules and microbial cell components (01/07/2008 - 01/07/2011)
- Maillard, Jean-Yves
Understanding the impact of different surfaces on the efficacy of selected wipe products (18/03/2022 - 31/10/2023)
- Maillard, Jean-Yves
Understanding the biomechanics of human skin tissue and micro-disruption of the skin barrier by transdermal delivery systems (TDS), such as the microneedle array device (MD) (01/06/2010 - 31/05/2011)
- Coulman, Sion
Understanding the association between E-cadherin loss and adverse response to endocrine agents in ER+ breast cancer (01/01/2015 - 31/01/2016)
- Hiscox, Stephen
Understanding how formulation parameters influence the performance of novel capsule formulations (01/07/2024 - 30/06/2027)
- Coulman, Sion
Understanding how ageing and the female gender contribute to mitochondrial dysfunction and the development of Alzheimer's disease (01/10/2019 - 31/03/2022)
- Kidd, Emma
Understanding how age and gender influence the development of Alzheimer's disease (01/10/2018 - 30/09/2021)
- Kidd, Emma
Treating progressive multiple sclerosis using a novel neuroprotective and anti-inflammatory approach (01/10/2015 - 15/11/2018)
- Mcguigan, Christopher
Translation of bacterial mediated therapeutic RNAi of solid tumours by demonstrating PARP inhibition in preclinical trials (30/06/2018 - 15/11/2018)
- Brancale, Andrea
-
- Smith, Mathew
Trace amines for restoring blood pressure and organ perfusion in sepsis (01/04/2022 - 31/03/2025)
- Ford, William
Towards validation of an immune suppressor protein from liver fluke as a drug target (01/10/2015 - 30/09/2018)
- Mcguigan, Christopher
Towards the repurposing of existing topical antimicrobials by ligand complexation (01/10/2015 - 25/01/2019)
- Heard, Charles
Towards the commercialisation of dual action mucoadhesive patches to treat periodontal disease (01/02/2017 - 31/01/2018)
- Heard, Charles
Towards devising a therapeutic strategy for patients with RRM2B-related mitochondrial (15/06/2018 - 31/07/2021)
- Mehellou, Youcef
Towards a nanomedicine-based broad-spectrum topical virucidal therapeutic system (01/10/2007 - 31/01/2011)
- Heard, Charles
Towards a magneto-optical sensor for sepsis (01/07/2012 - 26/08/2012)
- Allender, Christopher
To reduce microbial contamination on surfaces and infection by developing novel and effective antimicrobial surfaces (21/01/2019 - 17/03/2022)
- Maillard, Jean-Yves
To provide analytical and microscopy services, analysis of the components of surgical smoke generated by the use of diathermy (01/03/2015 - 30/04/2015)
- Birchall, James
Topical delivery of Melatonin Derivatives (01/06/2009 - 30/09/2009)
- Heard, Charles
To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01/09/2008 - 31/03/2010)
- Hutcheson, Iain
To evaluate the in-vitro potential of locally applied antibiotics to cause the development of bacterial resistance (02/01/2018 - 30/09/2018)
- Maillard, Jean-Yves
To embed expertise on the development of novel biochemical reagents to pathogens and exploit this knowledge to develop point-of-care products for the healthcare sector (07/06/2010 - 06/06/2012)
- Baillie, Les
To develop new biocidal products with efficacy particularly against mycobacteria and non-enveloped viruses (01/11/2016 - 31/12/2019)
- Maillard, Jean-Yves
To carry out experiments to investigate the diffusion of budesonide across ocular membranes (01/06/2010 - 31/05/2012)
- Allender, Christopher
Tissue engineering for human healing (12/04/2010 - 13/10/2011)
- Jones, Arwyn
The use of 3D culture to test the efficacy of a novel enzyme for cancer pro-drug therapy (01/02/2016 - 31/07/2016)
- Mcguigan, Christopher
The therapeutic potential of focal adhesion kinase in endocrine-responsive/resistant breast cancer and the HER2+breast cancer subtype (01/11/2010 - 31/07/2012)
- Hiscox, Stephen
The sporicidal activity of phoraid against Bacillus anthracis spores (01/02/2010 - 26/03/2010)
- Baillie, Les
The sporicidal activity of formalin, hydrogen peroxide, peracetic acid and bleach against Bacillus anthracis spores (01/06/2010 - 31/03/2011)
- Baillie, Les
The role of zinc transporters in cellular zinc signalling (01/08/2010 - 19/09/2015)
- Taylor, Kathryn
The role of caveolins in the processing of amyloid precursor protein (01/11/2010 - 29/02/2012)
- Kidd, Emma
The role of bacterial toxins in diabetes (01/07/2007 - 30/06/2010)
- Wann, Kenneth
Therapeutic modulation of C1s/C4A interactions to prevent schizophrenia (01/09/2023 - 30/11/2024)
- Heurich-Sevcenco, Meike
The involvement of lipid raft proteins in the processing of amyloid precursor protein (01/03/2012 - 30/06/2015)
- Kidd, Emma
The influence of altered endocytic protein expression on the predisposition to develop Alzheimer's disease (08/09/2014 - 30/06/2016)
- Kidd, Emma
The identification of B anthracis specific DNA probes (01/02/2015 - 31/10/2015)
- Baillie, Les
The GDNF neurosurgical clinical trial: listening to, and learning from the participant experience (19/10/2020 - 01/03/2023)
- Lane, Emma
The first preclinical analysis for a novel magnetically directed cancer treatment (01/08/2016 - 30/04/2017)
- Brancale, Andrea
The discovery of mitochondrial-targeting nucleotide prodrugs for the treatment of mitochondrial diseases (01/01/2019 - 30/04/2019)
- Mehellou, Youcef
The development of teriparatide loaded microarray system for improved compliance and persistence of the older patient to treat osteoporosis (01/04/2021 - 31/12/2024)
- Birchall, James
The design synthesis and evaluation of novel agents acting in the CNS (27/10/2014 - 08/01/2016)
- Mcguigan, Christopher
The controlled and targeted release of Potassium permanganates from a matrix into an aqueous interface (01/12/2014 - 30/09/2015)
The controlled and targeted delivery of potassium permanganate micro particles to wounds utilising the permipatch technology (01/10/2016 - 30/09/2017)
The contribution of the exosporium of bacillus anthracis to survival (ROLEEXOSPORIUM) (01/11/2007 - 31/12/2010)
- Baillie, Les
The biological evaluation of protide (01/03/2013 - 30/06/2014)
- Mcguigan, Christopher
Testng of the activity of Sanytol disinfectant wipes against Pseudononas aeruginosa (01/09/2014 - 30/09/2014)
- Maillard, Jean-Yves
Testing the virucidal activity of formulations against poliovirus (01/02/2016 - 29/02/2016)
- Maillard, Jean-Yves
Testing the virucidal activity of formulations against poliovirus (01/07/2015 - 31/12/2015)
- Maillard, Jean-Yves
Testing the Efficacy of two wipes based on the ASTM 2967-15 (01/07/2016 - 31/07/2016)
- Maillard, Jean-Yves
Testing the efficacy of pre-wetted sporicidal wipes (01/09/2016 - 31/10/2016)
- Maillard, Jean-Yves
Testing the antimicrobial activity of product (25/09/2017 - 31/12/2017)
- Maillard, Jean-Yves
Testing of the sporicidal activity of wipes against Clostridium difficile (29/04/2013 - 02/06/2013)
- Maillard, Jean-Yves
Testing of the sporicidal activity of "Schulke" wipe against clostridium difficile (01/09/2012 - 14/09/2012)
- Maillard, Jean-Yves
Testing of the sporicidal activity of PDI wipe against clostridium difficile (01/08/2011 - 14/08/2011)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 3 new products against clostridium difficle (16/01/2012 - 31/01/2012)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01/03/2009 - 13/01/2010)
- Maillard, Jean-Yves
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (29/03/2010 - 30/09/2011)
- Maillard, Jean-Yves
Testing of the sporiciadal activity of wipes against clostridium difficile (10/04/2012 - 13/04/2012)
- Maillard, Jean-Yves
Testing of the propensity of OxyBAC F31 RO (1331) to induce/select/trigger/bacterial resistance (01/07/2014 - 21/07/2014)
- Maillard, Jean-Yves
Testing of the propensity of Oxy BAC F31 RO (1331) to induce/select/trigger bacterial resistance (01/12/2014 - 09/02/2015)
- Maillard, Jean-Yves
Testing of the new sporicidal activity of 3 new products against clostridium difficile (30/01/2012 - 29/04/2012)
- Maillard, Jean-Yves
Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14/05/2012 - 31/05/2012)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01/09/2012 - 14/09/2012)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (28/01/2013 - 27/02/2013)
- Maillard, Jean-Yves
Testing of contamination of Alcoblow(r) (01/04/2013 - 14/04/2013)
- Maillard, Jean-Yves
Testing for broad spectrum efficacy of photosensitiser-based formulation (01/01/2020 - 31/07/2022)
- Maillard, Jean-Yves
Testing antimicrobial material acitvity (14/09/2015 - 13/01/2016)
- Maillard, Jean-Yves
Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01/10/2015 - 30/09/2018)
- Mcguigan, Christopher
Testing a new skin injection device (15/09/2021 - 28/02/2022)
- Birchall, James
Telehealth enabled medicines for care home residents (01/09/2014 - 31/12/2023)
- James, Delyth
Technology Transfer Workshop (15/03/2017 - 31/12/2017)
- Gumbleton, Mark
Targetting zinc signalling to prevent cell division in cancer (01/10/2015 - 30/09/2018)
- Taylor, Kathryn
Targeting zinc signalling to prevent cell division in cancer (01/10/2016 - 30/09/2018)
- Taylor, Kathryn
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01/10/2016 - 15/11/2018)
- Brancale, Andrea
Targeting natural products to counter the challenge of MRSA (01/10/2014 - 30/09/2017)
- Mcguigan, Christopher
Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01/11/2016 - 31/03/2018)
- Brancale, Andrea